Pudilan Xiaoyan oral liquid regulates tissue inflammation and apoptosis in mice with influenza virus pneumonia

Background:The influenza A virus is the primary cause of respiratory infections and poses a global health risk.Pudilan Xiaoyan oral liquid(PDL)exhibits anti-inflammatory and immunomodulatory properties.PDL is commonly employed in clinical practice to manage upper respiratory tract infections.However,there is still much to uncover regarding its potential therapeutic mechanism.Methods:Institute of cancer research mice were infected with influenza A virus via nasal drip.The general state of the mice,lung index,and lung index inhibition rate were used to evaluate the efficacy of PDL.Enzyme-linked immunosorbent assay,western blotting,and immunohistochemistry were used to observe the presence of proteins and cytokines in the lung tissue.Apoptosis was evaluated using the TUNEL assay.Results:PDL improved the mental state of influenza A virus-infected mice,reduced the lung index,and inhibited viral replication.The expression of interleukin-1βand tumor necrosis factor-αwere decreased,whereas the expression of interleukin-10 in the lung tissue was increased due to PDL treatment.In addition,PDL treatment modulated Toll-like receptor 4 and MyD88 expressions in the lung tissues.PDL significantly reduced apoptosis and decreased cleaved caspase-3 and PARP levels,whereas increased B-cell lymphoma-2 expression in the lung tissue.Notably,the moderate-dose group of PDL exhibited a more pronounced effect.These findings indicate that PDL exerts a protective effect against pneumonia injury in influenza A virus-infected mice.Conclusion:PDL inhibited the inflammatory response and regulated apoptosis by regulating Toll-like receptor 4 and MyD88 protein expressions,thereby protecting the lung tissue from viral infection-induced lung tissue injury.

Exploring the therapeutic effect of Xiaoyan d ecoction on lung cancer cachexia skeletal muscle atrophy based on L3-SMI

Background:Lung cancer cachexia has received widespread attention as one of the most common complications in patients with advanced lung cancer.As a multifactorial syndrome,lung cancer cachexia is characterized by a persistent decline in muscle mass that cannot be reversed by conventional nutrition Xiaoyan d ecoction can promote appetite and improve skeletal muscle mass in patients with lung cancer cachexia,while the third lumbar skeletal muscle index(L3-SMI)is able to determine whole-body skeletal muscle mass.To analyze the relationship between L3-SMI and hematological indexes and lung cancer cachexia,and to study the clinical efficacy of Xiaoyan decoction on skeletal muscle atrophy in lung cancer cachexia patients,with the aim of providing a reference basis for the early diagnosis and treatment of lung cancer cachexia patients and skeletal muscle atrophy.Methods:148 patients who were diagnosed with lung cancer in the Department of Oncology of the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine from January 2020 to December 2022 were included,and were divided into cachexia and non-cachexia groups according to the diagnostic criteria of cachexia,and analyzed the differences of hematological indexes and L3-SMI between cachexia patients and non-cachexia patients.And the patients with cachexia were divided into control group and treatment group,analyzed and compared the changes of body mass index(BMI),L 3-SMI,Karnofsky functional status score,albumin and other hematological indexes of the two groups before and after the treatment,and evaluated the safety of the Xiaoyan decoction in the treatment of cachexia.Results:A total of 148 lung cancer patients were included in this study,including 67 patients in the cachexia group and 81 patients in the non-cachexia group.According to the pre-treatment statistical analysis,the BMI of patients in the cachexia group was lower than that of patients in the non-cachexia group(P<0.05);among the biochemical function indexes,the proportions of creatinine(P<0.05),total protein(P<0.05),The levels of albumin in the cachexia group were significantly lower(P<0.05)compared to the non-cachexia group;in the cachexia group,both males and females had lower L3-SMIs than in the non-cachexia group(P<0.05).A total of 62 cases of lung cancer cachexia were studied,30 cases in the control group and 32 cases in the treatment group,according to statistical analysis,BMI was significantly different before and after treatment(P<0.05);L3-SMI was significantly different in the treatment group before and after treatment(P<0.05);Karnofsky significantly differed in the treatment group before and after treatment(P<0.05);and there was a significant difference in albumin before and after(P<0.05).Conclusion:Cachexia patients had significantly lower third lumbar skeletal muscle mass than non-cachexia patients,according to this study;Xiaoyan decoction was able to improve skeletal muscle mass,nutritional status as well as functional status of patients with cachexia in lung cancer,among others.

Quality Control of Zhuang Medicine Xiaoyan Zhiyang Lotion

[Objectives]To establish the TLC identification methods of Llicis Rotundae Cortex and Mahoniae Caulis and the determination method of syringin content in Zhuang Medicine Xiaoyan Zhiyang Lotion.[Methods]Thin layer chromatography(TLC)was used to qualitatively identify Llicis Rotundae Cortex and Mahoniae Caulis in Zhuang Medicine Xiaoyan Zhiyang Lotion.The quantitative analysis of syringin in Zhuang Medicine Xiaoyan Zhiyang Lotion was carried out by high-performance liquid chromatography(HPLC).Chromatographic conditions are as follows:Luna 5μm C_(18)((2)100 A(250 mm×4.6 mm,5μm)column was adopted;acetonitrile(10%)-water(90%)was as the mobile phase,and the flow rate was 1.0 mL/min;the detection wavelength was 265 nm;the sample size was 5μL;the column temperature was 30℃.[Results]Syringin had a good linear relationship with its peak area in the range of 0.190-2.856μg(R^(2)=0.9995).The RSD values of precision,stability and repeatability experiments were all lower than 2.5%,and the average sampling recovery rate(n=6)was 100.37%(RSD=-0.88%).[Conclusions]The method had the advantages of simple operation,strong specificity,good repeatability and stability,and can be used for the quality control of Zhuang Medicine Xiaoyan Zhiyang Lotion.

Clinical Observation and Safety Evaluation of Zhuang Medicine Xiaoyan Zhiyang Formula for Dermatosis

[Objectives]To observe the clinical efficacy and safety of Zhuang Medicine Xiaoyan Zhiyang Formula by retrospective analysis of clinical use.[Methods]A total of 225 cases were collected,including 117 males and 108 females,115 cases of contact dermatitis and 110 cases of acute eczema.Zhuang Medicine Xiaoyan Zhiyang Formula was administered to 225 patients with contact dermatitis and acute eczema and the clinical efficacy was evaluated.[Results]After one week of treatment,among 225 patients with contact dermatitis and acute eczema,76 cases were cured(33.78%),133 cases showed marked response(59.11%),16 cases(7.11%)were improved,0 case was ineffective,and the overall response rate was 92.89%.After one week of Zhuang Medicine Xiaoyan Zhiyang Formula treatment,the symptoms of itching,pain and swelling were significantly improved in all patients,and the rash was partially crusted without new symptom,and there were no complications and adverse reactions.[Conclusions]Zhuang Medicine Xiaoyan Zhiyang Formula therapy has a remarkable effect in the treatment of contact dermatitis and acute eczema.

Effects of Qingfei Xiaoyan pill combined with ceftriaxone and azithromycin on immune index, oxidative stress and inflammatory index in senile CAP patients

Objective: To explore the effects of Qingfei Xiaoyan pill combined with ceftriaxone and azithromycin on immune index, oxidative stress and inflammatory index in senile CAP patients. Methods: A total of 130 patients with CAP admitted to Yulin first hospital from October 2016 to December 2017 were randomly divided into control group (n = 65) and observation group (n = 65), the control group was treated with ceftriaxone combined with azithromycin, while the observation group was treated with Qingfei Xiaoyan Pill on the basis of the control group, the changes of cellular humoral immune function, oxidative stress index and inflammatory factors were compared between the two groups before and after treatment. Results: After treatment, the levels of CD4+ and CD4+/CD8+ in both groups were significantly higher than before treatment, while the level of CD8+ was significantly lower than before treatment, the levels of CD4+ and CD4+/CD8+ in the observation group were significantly higher than those in the control group, while the level of CD8+ was significantly lower than those in the control group;the levels of IgA and IgM in the observation group were significantly higher than those in the control group;the levels of MDA and SOD in the observation group were significantly lower than those in the control group, and the level of MDA in the observation group was significantly lower than that in the control group, the levels of SOD in the observation group were significantly higher than those in the control group;the levels of PCT and CRP in the two groups were significantly lower than those before treatment , and the levels of PCT and CRP in the observation group were significantly lower than those in the control group. Conclusions:Qingfei Xiaoyan pill combined with ceftriaxone and azithromycin can effectively enhance the immune function of elderly patients with CAP, enhance the body's antioxidant effect and reduce its inflammatory reaction, which is of clinical significance.

Laparoscopic Surgery and Modified Xiaoyan Lidan Decoction:An Effective Combination for Treating Cholecystitis with Cholelithiasis

Objective:To assess the clinical effects of combining laparoscopic surgery with Modified Xiaoyan Lidan Decoction in patients diagnosed with cholecystitis and cholelithiasis.Methods:Following the guidelines of the double-blind method,86 cases of cholecystitis with cholelithiasis were randomly divided into two groups,each comprising 43 cases.Both groups underwent laparoscopic surgery,with the observation group additionally receiving Modified Xiaoyan Lidan Decoction.A comparative analysis was conducted on clinical treatment effectiveness,general observation indicators,Traditional Chinese Medicine(TCM)syndrome scores,and the occurrence of adverse reactions between the two groups.Results:The observation group demonstrated a significantly higher overall clinical treatment effectiveness compared to the control group(P<0.05).The clinical symptom improvement time and hospitalization time were shorter in the observation group,and the pain score and TCM syndrome score after treatment were lower than those in the control group(P<0.05).No statistically significant difference was observed in the total reaction values(P>0.05).Conclusion:The combined application of laparoscopic surgery and Modified Xiaoyan Lidan Decoction can enhance clinical treatment efficiency for patients with cholecystitis and cholelithiasis.It facilitates a quicker improvement in clinical symptoms without causing serious adverse reactions,suggesting its potential for widespread adoption.

Professor Xiaoyan Wang's Experience in Treating Tinnitus with Qi Vacuity Pattern by Using Qi Monism

Tinnitus refers to the abnormal sound hallucinations in the ear or inside the skull when the patient lacks outside sound.In recent years,the incidence of tinnitus is increasing gradually,which seriously affects the quality of life of patients.Reducing tinnitus symptoms is one of the main purposes of clinical treatment.Professor Xiaoyan Wang applied the monism of Qi,combined with the dialectics of the six channels and the therapeutic effect was remarkable.

Variation in Chromosome Constitution of the Xiaoyan Series Partial Amphiploids and Its Relationship to Stripe Rust and Stem Rust Resistance

The wild relatives of wheat （Triticum aestivum L.） contain tremendous amounts of potentially useful genes and represent a promising source of genetic diversity for wheat improvement （Bommineni and Jauhar, 1997）. Thinopyrum ponticum （Popd.） Barkworth and D. R. Dewey [syn. Agropyron elongatum （Host） P. Beauv., Elytrigia pontica （Podp.） Holub, Lophopy- rum ponticum （Podp.） A. L6ve] （2n = 10x = 70）, has high crossability with various Triticum species. Numerous studies have shown that Th. ponticum carries many potentially valu- able resistance genes against biotic and abiotic stresses （Shannon, 1978; Cox, 1991; Zheng et al., 2014a,b）. Transferring the useful genes from Th. ponticum to common wheat through chromosome engineering had been a successful way to enhance the resistance of wheat to pests and diseases （Sharma et al., 1989; McIntosh, 1991）.

一测多评法测定莲芝消炎胶囊中4种二萜内酯

目的:建立一测多评法测定莲芝消炎胶囊中新穿心莲内酯等4种二萜内酯成分的含量。方法:色谱柱为Shimadzu Shim-pack C_(18)(250 mm×4.6 mm,5μm);流动相乙腈-0.1%磷酸水溶液,梯度洗脱;流速1.0 mL•min^(-1);检测波长为203 nm。以穿心莲内酯为参照,计算其他3种二萜内酯成分的相对校正因子,并测定其含量。结果:4种二萜内酯成分在各自范围内线性关系良好(r≥0.9999),平均加样回收率为100.0%~102.8%,RSD为1.1%~2.2%。一测多评法与外标法所得结果接近。结论:该方法快速准确,重复性好,可用于莲芝消炎胶囊的质量控制。

冬小麦突变新品系‘白鹿181’的遗传构成、品质分析及栽培技术

为了选育高产优质小麦新品种,服务国家粮食安全,本研究以‘小偃22’为试验材料,采用CO_(2)激光致死剂量辐射小麦品种‘小偃22’的种子,筛选突变株,检验其稳定性,分析其产量和品质,并探讨突变株‘白鹿181’新品系的栽培技术。结果表明:1)通过小麦660K芯片对‘小偃22’的突变株‘白鹿181’新品系进行遗传构成鉴定,共检测出630517个单核苷酸多态性(SNPs)位点,其中有1个不确定SNP位点,无差异SNPs位点442859个(占70.24%),差异SNPs位点187657个(占29.76%)。以‘小偃22’为模板,发现缺失和变异主要集中在AA、AC、AG、AT、CC、CG、GG、TC、TG和TT单核苷酸多态性(SNPs)上,其中AA、CC、GG和TT分别占19.23%、23.50%、23.40%和19.46%。2)与‘小偃22’相比,激光诱变产生的突变株‘白鹿181’的千粒重和产量3年平均增幅分别为9.31%和5.10%。3)‘白鹿181’的17种氨基酸含量均高于‘小偃22’,籽粒容重增加7.3%,湿面筋指数增加15.4%,稳定时间延长11.0%,最大拉伸阻力增加34.8%。4)不同施肥量和播种量对‘白鹿181’产量和千粒重均有不同程度的影响。从产量和千粒重综合考虑,在施750 kg·hm^(-2)氮肥条件下,每公顷播种180 kg种子的效益可实现最大化。研究结果表明,‘白鹿181’较适宜于关中平原等黄河中游地区种植,‘白鹿181’新品系的培育,为丰富我国小麦种质资源以及选育优质高产新品种提供了新材料。

马晓燕撷经典方剂治疗内科杂病经验浅谈

郁证的主要临床表现为情绪抑郁不宁、心胸满闷、胸部以及胁肋部胀痛,或有善哭易怒,亦或咽中如有炙脔等不适。相当于现代医学中的神经衰弱、癔症及焦虑症等。常因喜怒忧思,郁滞不舒,而导致肝疏泄功能失职,脾脏失其健运之功,心失其养,脏腑、气血、阴阳功能紊乱;而消渴常因禀赋不足亦或是饮食不节等因素导致阴津亏损,燥热偏盛,而出现“三多一少”的症状,即多饮、多尿、多食以及形体消瘦,相当于现代医学的“糖尿病”。马教授投身于对于郁证和消渴的证候及治疗的研究,熟读经典、精求古训,并且在长期的诊疗疾病过程中,对于使用经典方剂加减化裁辨治郁证和消渴等内科杂病积累了丰富的临床经验。现撷马教授以经典方剂治疗郁证和消渴等内科杂病的经验作总结与探析。其临床疗效确切。

HPLC法测定兰柏消炎膏中盐酸小檗碱的含量

目的:制备以黄柏为君药的兰柏消炎方的软膏剂,经过高效液相色谱法测定君药黄柏中的盐酸小檗碱的含量,为该制剂的工业化生产与质量控制提供参考。方法:以黄柏、侧柏叶、大黄、薄荷、泽兰等为主药制备兰柏消炎膏,采用高效液相色谱法测定其盐酸小檗碱的含量,以45∶55的比例将乙腈与0.1%的磷酸溶液混合,作为流动相溶液,其中每100 mL的流动相溶液中需要添加0.1 g的十二烷基磺酸钠。以1.0 mL·min^(-1)的流速操作,每次的采集量设定为10μL,并且所采集的光谱范围是265 nm,柱温为25℃的色谱条件下检测对兰柏消炎膏中的盐酸小檗碱进行测定,并进行方法学考察。结果:在该色谱条件下,溶剂和阴性溶液对盐酸小檗碱的测定无吸收峰的干扰。盐酸小檗碱的峰面积在11.8~141.6μg·mL^(-1)的浓度范围内呈现出上升趋势,其回归方程Y=38905X-65.441,R^(2)=0.9957,这表明盐酸小檗碱的峰面积与其浓度之间存在着良好的线性关联。结论:建立的盐酸小檗碱含量测定方法简便合理、准确,稳定可行,可用于兰柏消炎膏的质量控制。

消炎利胆片辅助胆囊切除术治疗急性结石性胆囊炎临床研究

目的:观察消炎利胆片辅助急性结石性胆囊炎的临床效果。方法:以随机数字表法将86例行胆囊切除术治疗的急性结石性胆囊炎患者分为2组,每组43例。对照组行胆囊切除术治疗,观察组在胆囊切除术后给予消炎利胆片治疗。比较2组临床疗效、胃肠功能恢复时间及并发症发生率,比较2组治疗前后血清超敏C-反应蛋白(hs-CRP)、降钙素原(PCT)水平。结果:观察组总有效率95.35%,高于对照组81.40%(P<0.05)。与对照组比较,观察组术后排气、肠鸣音恢复、进食及排便时间更早(P<0.05)。治疗后,2组血清hs-CRP、PCT水平均降低(P<0.05),且观察组低于对照组(P<0.05)。观察组并发症发生率6.98%,低于对照组23.26%(P<0.05)。结论:对急性结石性胆囊炎行胆囊切除术患者给予消炎利胆片治疗,有利于改善术后胃肠功能,减轻机体炎症反应,减少术后并发症,进一步提高临床疗效。

大青盐热敷联合康妇消炎栓塞肛治疗慢性盆腔痛临床观察

目的探讨大青盐热敷联合康妇消炎栓塞肛治疗慢性盆腔痛的效果。方法选择70例2020年1月—2022年2月就诊的慢性盆腔痛患者作为临床研究对象,根据双色球分组法分为2组,各35例。对照组单用康妇消炎栓塞肛治疗,观察组采用康妇消炎栓塞肛联合大青盐热敷治疗。获取2组患者的治疗效果、疼痛评分、中医证候积分、疾病复发率,并进行统计学比较。结果观察组治疗总有效率88.57%(31/35)高于对照组的74.29%(26/35),差异有统计学意义(P<0.05)。治疗后观察组患者的疼痛评分、主证评分与次证评分低于对照组,差异有统计学意义(P<0.05)。观察组疾病复发率11.43%(4/35)低于对照组的22.86%(8/35),差异有统计学意义(P<0.05)。结论慢性盆腔痛应用大青盐热敷联合康妇消炎栓塞肛,可提升治疗效果、改善疾病症状与疼痛症状、降低疾病复发率,值得临床借鉴。

基于VEGF/PI3K/AKT通路探讨消岩汤联合阿帕替尼抑制胃癌MGC-803细胞增殖的作用机制研究

[目的]明确消岩汤通过血管内皮生长因子(VEGF)/磷脂酰肌醇3激酶(PI3K)/丝苏氨酸蛋白激酶(AKT)通路治疗胃癌的作用机制。[方法]通过CCK-8检测消岩汤对MGC-803细胞增殖的影响;通过流式细胞术检测消岩汤对MGC-803细胞凋亡和周期的影响;通过蛋白免疫印迹(Western blot)检测消岩汤、阿帕替尼及其联合用药作用于MGC-803细胞后VEGF/PI3K/AKT信号通路相关蛋白的表达。[结果]消岩汤呈剂量依赖性抑制MGC-803细胞的增殖(P<0.05),其半抑制浓度(IC_(50))为63.56 mg/mL;随着消岩汤浓度的增加,MGC-803细胞的总凋亡率逐渐升高(P<0.05);随着消岩汤浓度的增加,MGC-803细胞的G0/G1期细胞所占百分比逐渐降低(P<0.05),S期细胞所占百分比逐渐升高(P<0.05),G2/M期细胞所占百分比变化不大(P>0.05);与空白对照组比较,消岩汤组、阿帕替尼组及其联合用药组的p-PI3K、p-AKT、Bcl-2、血管内皮生长因子A(VEGFA)和血管内皮细胞生长因子受体2(VEGFR-2)蛋白的表达量显著下调(P<0.05),Cleaved Caspase-9和Bax蛋白的表达量显著上调(P<0.05),相较于单药组,联合用药组对相关蛋白的调控作用更强。[结论]消岩汤能有效抑制人胃癌MGC-803细胞增殖,诱导凋亡以及S期阻滞,抗胃癌作用机制与其对VEGF/PI3K/AKT信号通路的调控相关。

消岩汤联合甲磺酸阿帕替尼对胃癌荷瘤小鼠移植瘤的抑瘤作用及机制研究

[目的]探讨消岩汤联合甲磺酸阿帕替尼对胃癌荷瘤小鼠移植瘤的抑瘤作用及抗肿瘤作用机制。[方法]将胃癌MFC细胞接种于BALB/c雄性小鼠皮下,成瘤后随机分为荷瘤模型组、消岩汤组、阿帕替尼组以及联合用药组,未造模的为空白对照组,每组5只。各组小鼠分别灌胃予生理盐水以及相应药物,连续给药14 d,观察记录小鼠生活状况及肿瘤体积变化。给药结束后处死各组小鼠,取肿瘤组织,称量质量记录,并利用蛋白免疫印迹(Western Blot)法检测瘤组织中磷脂酰肌醇3-激酶(PI3K)/丝苏氨酸蛋白激酶(AKT)信号通路及血管新生相关蛋白的表达。[结果]观察各组小鼠的生活状况显示,消岩汤组和阿帕替尼组小鼠的生活状况较荷瘤模型组有所改善,联合用药组小鼠改善更为明显;与荷瘤模型组比较,消岩汤组、阿帕替尼组以及联合用药组的肿瘤体积及质量明显降低,联合用药组降低更为明显;相较于荷瘤模型组,消岩汤组、阿帕替尼组以及联合用药组的p-PI3K、p-AKT、Bcl-2、基质金属蛋白酶(MMP)-9、MMP-2、血管内皮生长因子A(VEGFA)和血管内皮生长因子受体-2(VEGFR-2)的蛋白表达明显下调,Cleaved Caspase-9、Bax的蛋白表达明显上调,差异均具有统计学意义(P<0.05),与单药组比较,联合用药组对PI3K/AKT信号通路及血管新生相关蛋白表达的调控作用更为明显。[结论]消岩汤联合阿帕替尼可通过调控PI3K/AKT信号通路和血管新生相关蛋白的表达,有效抑制胃癌小鼠移植瘤的生长,改善小鼠生活状况。

不同中成药辅助治疗社区获得性肺炎疗效及安全性的网状Meta分析

目的采用网状Meta分析探讨不同中成药辅助治疗社区获得性肺炎(CAP)的疗效及安全性。方法计算机检索中国知网、万方数据知识服务平台、维普网、中国生物医学文献数据库及PubMed、Web of Science、Embase、the Cochrane Library中公开发表的中成药治疗CAP的随机对照试验(RCTs),检索时限为建库至2023年5月。由2位研究员独立筛选文献,采用Cochrane风险偏倚评估工具RoB 2.0对纳入文献进行方法学质量评价,应用Stata 15.0软件进行网状Meta分析,并绘制漏斗图评估文献发表偏倚。结果最终纳入31篇RCTs,共包含3111例患者。网状Meta分析结果显示,临床总有效率的累积排序概率曲线下面积(SUCRA)排序为:十味龙胆花颗粒>疏风解毒胶囊>连花清瘟胶囊/颗粒>蒲地蓝消炎口服液>西药;退热时间的SUCRA排序为:十味龙胆花颗粒>连花清瘟胶囊/颗粒>疏风解毒胶囊>蒲地蓝消炎口服液>西药;咳嗽消失时间的SUCRA排序为:十味龙胆花颗粒>疏风解毒胶囊=连花清瘟胶囊/颗粒>蒲地蓝消炎口服液>西药;肺部啰音消失时间的SUCRA排序为:十味龙胆花颗粒>疏风解毒胶囊>连花清瘟胶囊/颗粒>西药。与单独西药治疗相比,十味龙胆花颗粒、疏风解毒胶囊、连花清瘟胶囊/颗粒、蒲地蓝消炎口服液联合西药治疗的临床总有效率均较高。与单独西药治疗相比,十味龙胆花颗粒、连花清瘟胶囊/颗粒、疏风解毒胶囊联合西药治疗者的退热时间、咳嗽消失时间、肺部啰音消失时间更短;与连花清瘟胶囊/颗粒、疏风解毒胶囊、蒲地蓝消炎口服液联合西药相比,十味龙胆花颗粒联合西药治疗者退热时间、咳嗽消失时间更短;与疏风解毒胶囊、连花清瘟胶囊/颗粒联合西药相比,十味龙胆花颗粒联合西药治疗者的肺部啰音消失时间更短。研究均未出现严重不良反应。漏斗图结果显示,有少部分散点分布在下部,散点存在不对称性,故文献存在一定的发表偏倚。结论连花清瘟胶囊/颗粒、疏风解毒胶囊、蒲地蓝消炎口服液、十味龙胆花颗粒联合西药治疗CAP均可增强疗效,但十味龙胆花颗粒的治疗效果最好,疏风解毒胶囊次之。

基于多组分定量联合主成分分析正交偏最小二乘法-判别分析及熵权优劣解距离法的抗菌消炎胶囊质量差异性评价

目的建立主成分分析(PCA)、正交偏最小二乘法-判别分析(OPLS-DA)及熵权优劣解距离法(EW-TOPSIS)评价抗菌消炎胶囊的多组分质量差异。方法采用高效液相色谱法(HPLC)同时测定15批抗菌消炎胶囊中獐牙菜苦苷、獐牙菜苷、绿原酸、3,5-二-O-咖啡酰奎宁酸、知母皂苷BⅡ、知母皂苷AⅢ、原百部碱、对叶百部碱、黄芩苷、汉黄芩苷、黄芩素和汉黄芩素的含量,借助PCA、OPLS-DA及EW-TOPSIS模型对15批消炎胶囊样品进行质量差异分析,筛选出导致差异的特征成分,并进行质量排序。结果12种成分在各自范围内呈现良好的线性关系(r>0.999),平均加样回收率(n=9)96.90%~100.23%(RSD<2.0%)。化学计量学筛选出2个主成分,方差贡献率累计达95.172%;OPLS-DA发掘出黄芩苷、绿原酸、知母皂苷BⅡ和对叶百部碱对抗菌消炎胶囊质量有显著影响;EW-TOPSIS分析结果显示Ci值0.0827~0.8495,15批样品质量差异较大。结论所建立的方法可用于抗菌消炎胶囊质量的综合评价。

消炎散联合穴位贴敷治疗急性期膝关节滑膜炎临床观察

目的 观察消炎散联合穴位贴敷治疗急性期膝关节滑膜炎的疗效。方法 将湖南中医药大学第二附属医院60例急性期膝关节滑膜炎患者随机分为2组,口服塞来昔布及骨科常规护理为对照组;对照组基础上外敷消炎散联合穴位贴敷为治疗组。7 d为1个疗程,共2个疗程。比较2组治疗前后滑膜超声指标、膝关节疼痛与功能、炎症指标及疗效评估。结果 治疗组总有效率显著高于对照组;与治疗前相比,2组治疗后的疼痛强度评分(NRS)、骨关节炎指数(WOMAC)、C反应蛋白(CRP)、红细胞沉降率(ESR)、白细胞介素-6(IL-6)等血清炎症指标均较治疗前下降。且治疗组的NRS、WOMAC及CRP、ESR、IL-6低于对照组,差异具有统计学意义(P<0.05)。结论 消炎散联合穴位贴敷可降低炎症因子,有效缓解患者膝关节疼痛并改善关节活动度,改善患者生活质量。

蒲地蓝消炎口服液配合阿昔洛韦、干扰素α-2b治疗儿童疱疹性咽峡炎临床研究

目的:观察蒲地蓝消炎口服液配合阿昔洛韦、干扰素α-2b治疗儿童疱疹性咽峡炎的临床疗效。方法:将104例疱疹性咽峡炎患儿以随机数字表法分为观察组与参照组各52例,参照组给予阿昔洛韦联合干扰素α-2b治疗,观察组在参照组基础上配合蒲地蓝消炎口服液治疗。比较2组临床疗效、症状缓解时间,并比较2组治疗前后中医证候积分、血清炎症因子及免疫球蛋白水平。结果:观察组总有效率96.15%,高于参照组的82.69%(P<0.05)。治疗后,2组中医证候积分均降低(P<0.05),且观察组低于参照组(P<0.05)。观察组退热时间、疼痛消失时间、疱疹消退时间及食欲恢复正常时间均短于参照组(P<0.05)。治疗后,2组血清白细胞介素-6 (IL-6)、白细胞介素-10 (IL-10)、肿瘤坏死因子-α (TNF-α)水平均降低(P<0.05),且观察组低于参照组(P<0.05)。治疗后,2组血清免疫球蛋白A (IgA)、免疫球蛋白G (IgG)及免疫球蛋白M (IgM)水平均升高(P<0.05),且观察组高于参照组(P<0.05)。结论:针对疱疹性咽峡炎患儿给予蒲地蓝消炎口服液配合阿昔洛韦、干扰素α-2b治疗效果显著,可促进患儿症状及体征改善,减轻机体炎症反应,提高免疫功能。